腔内修复术治疗113例主动脉夹层瘤的临床分析  

Thoracic endovascular aortic repair for aortic dissection:a clinical analysis of 113 cases

作　　者：罗剑渊[1] 王家平[1] 杨达宽[1] 杨绍军[1] 李迎春[1] 童玉云[1] 周云[1] 袁曙光[1] 杨青[1] 李松蔚[1] 李琳[1] 丁丽丽[1] 

机构地区：[1]昆明医学院第二附属医院,650101

出　　处：《介入放射学杂志》2011年第4期269-272,共4页Journal of Interventional Radiology

摘　　要：目的评价腔内修复术治疗主动脉夹层的疗效,探讨主动脉夹层的治疗策略。方法回顾分析2002年3月-2010年6月,113例采用腔内修复术治疗的主动脉夹层患者的临床资料、治疗和随访结果。结果腔内修复术治疗主动脉夹层的手术成功率99.1%(112/113),围手术期无严重并发症发生,术后30 d病死率1.8%(2/113)。105例患者获术后随访,平均随访时间28个月,术后1、5年累计生存率分别为99.1%和97.1%。结论腔内修复术具有微创、安全、有效的优点,逐渐成为治疗Standford B型主动脉夹层的首选方法。Standford A型主动脉夹层的腔内修复术正处于探索阶段。Objective To evaluate the effectiveness of thoracic endovascular aortic repair（TEVAR）in treating aortic dissection（AD）and to discuss the treatment strategy for AD.Methods From March 2002 to June 2010 in authors＇ hospital TEVAR was performed in 113 patients with AD.The clinical data,the therapeutic measures and the follow-up results were retrospectively analysed.Results The technical success rate was 99.1%（112/113）,no serious complications occurred in perioperative period.The cumulative mortality rate at 30 days after the procedure was 1.8%（2/113）.A follow-up with a mean period of 28 months was carried out in 105 patients.The one-year and five-year cumulative survival rate was 99.1% and 97.1% respectively.Conclusion TEVAR is a safe,effective and minimally invasive technique for the treatment of AD.This technique is gradually becoming the treatment of first choice for aortic dissection of Standford type B.TEVAR for the treatment of Standford type A aortic dissection is still in an exploratory stage.

关 键 词：动脉瘤 夹层 血管腔内修复 支架 

分 类 号：R543.16[医药卫生—心血管疾病]